Federal contractor · public award history
INTERNATIONAL AIDS VACCINE INITIATIVE INC.
DBA INTERNATIONAL AIDS VACCINE INITIATIVE INC
Parent: INTERNATIONAL AIDS VACCINE INITIATIVE INC. ZEJBC8JQM3P5
- Awards we know about
- 9
- Typical size
- $2.25M
- Middle of their public awards
- Dollars on those awards
- $109.94M
Most of their awards we can see fall roughly between $216,964 and $5.82M.
From official USAspending contract records — not a capability rating, past-performance score, or recommendation to team or bid.
Public award activity by year
Sum of award values in our USAspending index (not a full financial history).
- 2024$3.63M
- 2025$106.31M
Awarding agencies
- Department of Health and Human Services (9)
Industries & product codes
Award history
- Department of Health and Human Services$2.25M
THIS TASK ORDER IS TO DEVELOP AN OPTIMIZED PHASE 1 CGMP MANUFACTURING PROCESS FOR LIPID NANOPARTICLE (LNP) FABRICATION THAT ENABLE COVALENT COUPLING OF AN HIV-1 ENV TRIMER TO THE SURFACE OF THE LNP. A NON-GMP PROCESS RUN OF DRUG PRODUCT SHALL BE PERF
- Department of Health and Human Services$20,264
INTERNATIONAL AIDS VACCINE INITIATIVE FY20 BASE AWARD PROCESS DEVELOPMENT FOR VACCINE CANDIDATES INCLUDING SARS COV 2 COV CAN 8044363 TOTAL $20,264.00
- Department of Health and Human Services—
MANUFACTURING AND CHARACTERIZATION SERVICES FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES
- Department of Health and Human Services$8.01M
PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR HIV AND OTHER CANDIDATE AGENTS
- Department of Health and Human Services—
IGF::OT::IGF NIAID PROCESS AND ANALYTICAL SUPPORT FOR DEVELOPMENT OF HIV VACCINES
- Department of Health and Human Services$177,790
COORDINATION AND TECHNICAL SUPPORT
- Department of Health and Human Services$256,138
COORDINATION AND TECHNICAL SUPPORT
- Department of Health and Human Services$95.59M
THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN
- Department of Health and Human Services$3.63M
CONTRACT HHSN272201800010I INTERNATIONAL AIDS VACCINE INITIATIVE MANUFACTURE OF INFLUENZA VIRUS HUMAN CHALLENGE MATERIAL FOR PHASE I AND II CLINICAL TESTING
Intelligence only — not legal advice, not a past-performance evaluation, and not a recommendation to team or bid. Verify on USAspending and SAM.gov.